FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Katoh M, Loriot Y, Brandi G, Tavolari S, et al. Nat Rev Clin Oncol 2024;21:312-329.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Katoh M, Loriot Y, Brandi G, Tavolari S, et al. FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Nat Rev Clin Oncol 2024;21:312-329.
PMID: 38424198